Table 1 Important clinical features and demographics of the studied individuals
| Â | Controls | Cases | ||||
|---|---|---|---|---|---|---|
| Â | All | Male | Female | All | Male | Female |
CAD | 2292 | 1245(0.54) | 1047(0.46) | 2323 | 1777(0.76) | 546(0.24) |
MI | 853 | 558(0.65) | 295(0.35) | 2180 | 1682(0.77) | 498(0.23) |
T2DM | 954 | 524(0.55) | 430(0.45) | 1589 | 1175(0.74) | 414(0.26) |
HTN | 1559 | 828(0.53) | 731(0.47) | 1962 | 1474(0.75) | 488(0.25) |
hChol | 593 | 312(0.53) | 281(0.47) | 1078 | 796(0.74) | 282(0.26) |
lHDL | 729 | 487(0.67) | 242(0.33) | 1181 | 979(0.83) | 202(0.17) |
hTG | 427 | 267(0.63) | 160(0.37) | 728 | 554(0.76) | 174(0.24) |
hLDL | 886 | 456(0.51) | 430(0.49) | 965 | 717(0.74) | 248(0.26) |
FH | 542 | 299(0.55) | 243(0.45) | 359 | 287(0.80) | 72(0.20) |
OBS | 888 | 385((0.43) | 503(0.57) | 857 | 573(0.67) | 284(0.33) |
Smokers | 685 | 639(0.93) | 46(0.07) | 1059 | 1031(0.97) | 28(0.03) |
VD 1 | 0 | 0 | 0 | 885 | 642(0.73) | 243(0.27) |
2 | 0 | 0 | 0 | 456 | 356(0.78) | 100(0.22) |
3 | 0 | 0 | 0 | 965 | 717(0.74) | 248(0.26) |
Clinical characteristics | Â | Â | Â | Â | Â | Â |
Age | 50.6 ± 0.4 | 51.2 ± 0.5 | 49.8 ± 0.5 | 60.3 ±0.2 | 59.8 ± 0.3 | 61.8 ± 0.54 |
BMI | 29.0 ±0.2 | 27.97 ± 0.2 | 30.3 ± 0.3 | 28.9 ± 0.1 | 28.3 ± 0.1 | 31.0 ± 0.3 |
Total Chol | 4.51 ± 0.02 | 4.42 ± 0.03 | 4.62 ± 0.03 | 4.48 ± 0.02 | 4.43 ±0.03 | 4.66 ± 0.05 |
HDL-Chol | 1.26 ±0.01 | 1.18 ±0.03 | 1.33 ±0.01 | 1.15 ±0.01 | 1.15 ± 0.01 | 1.25 ± 0.02 |
LDL-Chol | 2.76 ± 0.02 | 2.73 ± 0.03 | 2.80 ±0.03 | 2.71 ±0.02 | 2.68 ± 0.02 | 2.84 ±0.06 |
TG | 1.52 ± 0.02 | 1.60 ± 0.03 | 1.44 ± 0.03 | 1.78 ± 0.02 | 1.78 ± 0.03 | 1.78 ± 0.05 |
Fasting glucose | 6.87 ± 0.16 | 6.80 ± 0.23 | 6.92 ± 0.22 | 9.45 ± 0.31 | 9.27 ± 0.37 | 9.88 ± 0.56 |
BP | 120/83 | 119/81 | 121/82 | 128/84 | 130/85 | 127/83 |